These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 27524289)

  • 1. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
    Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
    Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
    Möller M; Du Preez JL; Harvey BH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites.
    Yan J; Han VX; Heng B; Guillemin GJ; Bandodkar S; Dale RC
    EBioMedicine; 2022 Mar; 77():103917. PubMed ID: 35279631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
    Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
    Widner B; Leblhuber F; Fuchs D
    J Neural Transm (Vienna); 2002 Feb; 109(2):181-9. PubMed ID: 12075858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring.
    Tong Q; Song J; Yang G; Fan L; Xiong W; Fang J
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29193181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes.
    Fujigaki S; Saito K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
    Arch Biochem Biophys; 1998 Oct; 358(2):329-35. PubMed ID: 9784247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
    Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
    Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma.
    Orsatti L; Speziale R; Orsale MV; Caretti F; Veneziano M; Zini M; Monteagudo E; Lyons K; Beconi M; Chan K; Herbst T; Toledo-Sherman L; Munoz-Sanjuan I; Bonelli F; Dominguez C
    J Pharm Biomed Anal; 2015 Mar; 107():426-31. PubMed ID: 25668794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of l-tryptophan and l-kynurenine derivatized with (R)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2,1,3-benzoxadiazole by LC-MS/MS on a triazole-bonded column and their quantification in human serum.
    Takahashi S; Iizuka H; Kuwabara R; Naito Y; Sakamoto T; Miyagi A; Onozato M; Ichiba H; Fukushima T
    Biomed Chromatogr; 2016 Sep; 30(9):1481-6. PubMed ID: 26910189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of kynurenine pathway metabolites, neurotransmitters and their metabolites in blood plasma and brain tissue of individuals with latent toxoplasmosis.
    Vondroušová J; Mikoška M; Syslová K; Böhmová A; Tejkalová H; Vacek L; Kodym P; Krsek D; Horáček J
    J Pharm Biomed Anal; 2019 Jun; 170():139-152. PubMed ID: 30925271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease.
    Karlsson T; Strand E; Dierkes J; Drevon CA; Øyen J; Midttun Ø; Ueland PM; Gudbrandsen OA; Pedersen ER; Nygård O
    Eur J Nutr; 2017 Feb; 56(1):261-272. PubMed ID: 26482150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered neopterin and IDO in kynurenine metabolism based on LC-MS/MS metabolomics study: Novel therapeutic checkpoints for type 2 diabetes mellitus.
    Liu Z; Ma Z; Jin L; Nizhamuding X; Zeng J; Zhang T; Zhang J; Wang J; Zhao H; Zhou W; Zhang C
    Clin Chim Acta; 2024 Apr; 557():117859. PubMed ID: 38518968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine and its metabolites in Alzheimer's disease patients.
    Gulaj E; Pawlak K; Bien B; Pawlak D
    Adv Med Sci; 2010; 55(2):204-11. PubMed ID: 20639188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
    Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.
    Yan J; Kothur K; Innes EA; Han VX; Jones HF; Patel S; Tsang E; Webster R; Gupta S; Troedson C; Menezes MP; Antony J; Ardern-Holmes S; Tantsis E; Mohammad S; Wienholt L; Pires AS; Heng B; Guillemin GJ; Guller A; Gill D; Bandodkar S; Dale RC
    EBioMedicine; 2022 Oct; 84():104280. PubMed ID: 36174397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.